Contrast response properties of magnocellular and parvocellular pathways in retinitis pigmentosa assessed by the visual evoked potential

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 8, 2005, Pages 2967-2973

  Alexander, Kenneth R ^a   Rajagopalan, Aruna S ^a   Seiple, William ^a,b   Zemon, Vance M ^c   Fishman, Gerald A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YESHIVA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLOR VISION; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; FEMALE; FOURIER ANALYSIS; GIANT CELL; HUMAN; LUMINANCE; MALE; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; VISUAL ACUITY; CONTRAST SENSITIVITY; GENICULATE BODY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VISUAL SYSTEM;

ADULT; CONTRAST SENSITIVITY; EVOKED POTENTIALS, VISUAL; FEMALE; GENICULATE BODIES; HUMANS; MALE; MIDDLE AGED; RETINITIS PIGMENTOSA; VISUAL PATHWAYS;

EID: 24644451236     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0231     Document Type: Article

References (40)

1. Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Gen. 2002;11:1219-1227.
2. Flannery JG, Farber DB, Bird AC, Bok D. Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1989;30:191-211.
3. Stone JL, Barlow WE, Humayun MS, de Juan E, Milam AH. Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa. Arch Ophthalmol. 1992;110:1634-1639.
4. Santos A, Humayun MS, de Juan EJ et al. Preservation of the inner retina in retinitis pigmentosa: a morphometric analysis. Arch Ophthalmol. 1997;115:511-515.
5. Grover S, Fishman GA, Alexander KR, Anderson RJ, Derlacki DJ. Visual acuity impairment in patients with retinitis pigmentosa. Ophthalmology. 1996;103:1593-1600.
6. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 2003;22:607-655.
7. Wolkstein M, Atkin A, Bodis-Wollner I. Contrast sensitivity in retinal disease. Ophthalmology. 1980;87:1140-1149.
8. Marmor MR. Contrast sensitivity and retinal disease. Ann Ophthalmol. 1981;13:1069-1071.
9. Hyvärinen L, Rovamo J, Laurinen P, Peltomaa A. Contrast sensitivity function in evaluation of visual impairment due to retinitis pigmentosa. Acta Ophthalmol. 1981;59:763-773.
10. Lindberg CR, Fishman GA, Anderson RJ, Vasquez V. Contrast sensitivity in retinitis pigmentosa. Br J Ophthalmol. 1981;65:855-858.
11. Sucs FE, Uvijls A. Contrast sensitivity in retinitis pigmentosa at different luminance levels. Clin Vision Sci. 1992;7:147-151.
12. Akeo K, Hiida Y, Saga M, Inoue R, Oguchi Y. Correlation between contrast sensitivity and visual acuity in retinitis pigmentosa patients. Ophthalmologica. 2002;216:185-191.
13. Alexander KR, Derlacki DJ, Fishman GA. Contrast thresholds for letter identification in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1992;33:1846-1852.
14. Haymes S, Guest D, Heyes A, Johnston A. Mobility of people with retinitis pigmentosa as a function of vision and psychological variables. Optom Vision Sci. 1996;73:621-637.
15. Turano K, Gurschat DR, Stahl JW, Massof RW. Perceived visual ability for independent mobility in persons with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1999;40:865-877.
16. Szlyk JP, Seiple W, Fishman GA, Alexander KR, Grover S, Mahler CL. Perceived and actual performance of daily tasks: relationship to visual function tests in patients with retinitis pigmentosa. Ophthalmology. 2001;108:65-75.
17. Kaplan E, Lee BB, Shapley RM. New views of primate retinal function. In: Osborne NN, Chader GT, eds. Progress in Retinal Research. Oxford: Pergamon Press; 1990:273-336.
18. Silveira LC, Saito CA, Lee BB, et al. Morphology and physiology of primate M- and P-cells. Prog Brain Res. 2004;144:21-46.
19. Pokorny J, Smith VC. Psychophysical signatures associated with magnocellular and parvocellular pathway contrast gain. J Opt Soc Am A. 1997;14:2477-2486.
20. Leonova A, Pokorny J, Smith VC. Spatial frequency processing in inferred PC- and MC-pathways. Vision Res. 2003;43:2133-2139.
21. Alexander KR, Barnes CS, Fishman GA, Pokorny J, Smith VC. Contrast sensitivity deficits in inferred magnocellular and parvocellular pathways in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2004;45:4510-4519.
22. Alexander KR, Pokorny J, Smith VC, Fishman GA, Barnes CS. Contrast discrimination deficits in retinitis pigmentosa are greater for stimuli that favor the magnocellular pathway. Vision Res. 2001;41:671-683.
23. Alexander KR, Barnes CS, Fishman GA. Deficits in temporal integration for contrast processing in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2003;44:3163-3169.
24. Hess RF, Bradley A. Contrast perception above threshold is only minimally impaired in human amblyopia. Nature. 1980;287:463-464.
25. Greenstein VC, Seliger S, Zemon V, Ritch R. Visual evoked potential assessment of the effects of glaucoma on visual subsystems. Vision Res. 1998;38:1901-1911.
26. Butler PD, Schechter I, Zemon V, et al. Dysfunction of early stage visual processing in schizophrenia. Am J Psychiatry. 2001;158:1126-1133.
27. Ross DF, Fishman GA, Gilbert LD, Anderson RJ. Variability of visual field measurements in normal subjects and patients with retinitis pigmentosa. Arch Ophthalmol. 1984;102:1004-1010.
28. Fishman GA, Anderson RJ, Lourenço PC. Prevalence of posterior subcapsular lens opacities in patients with retinitis pigmentosa. Br J Ophthalmol. 1985;69:263-266.
29. Alexander KR, Derlacki DJ, Fishman GA. Visual acuity vs. letter contrast sensitivity in retinitis pigmentosa. Vision Res. 1995;35:1495-1499.
30. Zemon V, Gordon J, Welch J. Asymmetries in ON and OFF visual pathways of humans revealed using contrast-evoked cortical potentials. Vis Neurosci. 1988;1:145-150.
31. Paranhos FRL, Katsum O, Arai M, Nehemy MB, Hirose T. Pattern reversal visual evoked response in retinitis pigmentosa. Doc Ophthalmol. 1998-1999;96:321-331.
32. Dagnelie G, Massof RW. Foveal cone involvement in retinitis pigmentosa progression assessed through flash-on-flash parameters. Invest Ophthalmol Vis Sci. 1993;34:231-242.
33. Swanson WH, Ueno T, Smith VC, Pokorny J. Temporal modulation sensitivity and pulse detection thresholds for chromatic and luminance perturbations. J Opt Soc Am A. 1987;4:1992-2005.
34. Burns SA, Elsner AE, Kreitz MR. Analysis of non-linearities in the flicker ERG. Optom Vision Sci. 1992;69:95-105.
35. Seiple WH, Siegel IM, Carr RE, Mayron C. Evaluating macular function using the focal ERG. Invest Ophthalmol Vis Sci. 1986;27:1123-1130.
36. Iarossi G, Falsini B, Piccardi M. Regional cone dysfunction in retinitis pigmentosa evaluated by flicker ERGs: relationship with perimetric sensitivity losses. Invest Ophthalmol Vis Sci. 2003;44:866-874.
37. Bernander Ö, Douglas RJ, Martin KAC, Koch C. Synaptic background activity influences spatiotemporal integration in single pyramidal cells. Proc Natl Acad Sci USA. 1991;88:11569-11573.
38. Kaplan E, Benardete E. The dynamics of primate retinal ganglion cells. Prog Brain Res. 2001;134:17-34.
39. Alexander KR, Barnes CS, Fishman GA. ON-pathway dysfunction and timing properties of the flicker ERG in carriers of X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2003;44:4017-4025.
40. Merigan WH, Maunsell JHR. How parallel are the primate visual pathways? Ann Rev Neurosci. 1993;16:369-402.